Microarray analysis of gene expression in Men1 knockout embryoid body reveals genetic events involved in early mouse embryonic development

Biochemical and Biophysical Research Communications

Volumn 352, Issue 2, 2007, Pages 456-462

  Zhang, Hong Li ^a,b   Luo, Tian Hong ^a,b   Feng, Ling ^a   Zhao, Yu ^a,b   Li, Wen Yi ^a   Xu, Jia ^a   Zhang, Qin ^a   Xu, Li Hong ^a   Zheng, Sheng ^a,b   Li, Guo ^a   Luo, Min ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Development; Embryoid body; Men1; Microarray

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PROTEIN; PROTEIN BTC; PROTEIN HOX9; PROTEIN IGF2; PROTEIN KITL; PROTEIN NFATC1; PROTEIN POSTN; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX4; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; GENE TARGETING; HEART; LIVER; MEN1 GENE; MOLECULAR MODEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKULL; WILD TYPE;

ANIMALS; EMBRYO; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANOGENESIS; PROTO-ONCOGENE PROTEINS;

EID: 33845202902     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.031     Document Type: Article

References (30)

1. Thakker R.V. Multiple endocrine neoplasia type 1. In: De Groot L.J., Besser G., Jameson J., Loriaux D., Marshall J., Odell W., Potts J., and Rubersteinp A. (Eds). Endocrinology (1995), Saunders Press, Philadelphia 2815-2831
2. Larsson C., Skogseid B., Oberg K., Nakamura Y., and Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 (1988) 85-87
3. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., and Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 (1997) 404-407
4. Agarwal S.K., Debelenko L.V., Kester M.B., Guru S.C., Manickam P., Olufemi S.E., Skarulis M.C., Heppner C., Crabtree J.S., Lubensky I.A., Zhuang Z., Kim Y.S., Chandrasekharappa S.C., Collins F.S., Liotta L.A., Spiegel A.M., Burns A.L., Emmert-Buck M.R., and Marx S.J. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families. Hum. Mutat. 12 (1998) 75-82
5. Guru S.C., Goldsmith P.K., Burns A.L., Marx S.J., Spiegel A.M., Collins F.S., and Chandrasekharappa S.C. Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA 95 (1998) 1630-1634
6. Agarwal S.K., Guru S.C., Heppner C., Erdos M.R., Collins R.M., Park S.Y., Saggar S., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Marx S.J., and Burns A.L. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 (1999) 143-152
7. Kaji H., Canaff L., Lebrun J.J., Goltzman D., and Hendy G.N. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc. Natl. Acad. Sci. USA 98 (2001) 3837-3842
8. Lemmens I.H., Forsberg L., Pannett A.A., Meyen E., Piehl F., Turner J.J., Van de Ven W.J., Thakker R.V., Larsson C., and Kas K. Menin interacts directly with the homeobox-containing protein. Pem. Biochem. Biophys. Res. Commun. 286 (2001) 426-431
9. Ohkura N., Kishi M., Tsukada T., and Yamaguchi K. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochem. Biophys. Res. Commun. 282 (2001) 1206-1210
10. Heppner C., Bilimoria K.Y., Agarwal S.K., Kester M., Whitty L.J., Guru S.C., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Marx S.J., and Burns A.L. The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 (2001) 4917-4925
11. Sukhodolets K.E., Hickman A.B., Agarwal S.K., Sukhodolets M.V., Obungo V.H., Novotny E.A., Crabtree J.S., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Burns A.L., and Marx S.J. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol. Cell. Biol. 23 (2003) 493-495
12. Stewart C., Parente F., Piehl F., Farnebo F., Quincey D., Silins G., Bergman L., Carle G.F., Lemmens I., Grimmond S., Xian C.Z., Khodei S., Teh B.T., Lagercrantz J., Siggers P., Calender A., Van de Vem V., Kas K., Weber G., Hayward N., Gaudray P., and Larsson C. Characterization of the mouse Men1 gene and its expression during development. Oncogene 17 (1998) 2485-2493
13. Crabtree J.S., Scacheri P.C., Ward J.M., Garrett-Beal L., Emmert-Buck M.R., Edgemon K.A., Lorang D., Libutti S.K., Chandrasekharappa S.C., Marx S.J., Spiegel A.M., and Collins F.S. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc. Natl. Acad. Sci. USA 98 (2001) 1118-1123
14. Bertolino P., Radovanovic I., Casse H., Aguzzi A., Wang Z.Q., and Zhang C.X. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech. Dev. 120 (2003) 549-560
15. Leahy A., Xiong J.W., Kuhnert F., and Stuhlmann H. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J. Exp. Zool. 284 (1999) 67-81
16. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25 (2000) 25-29
17. Yokoyama A., Wang Z., Wysocka J., Sanyal M., Aufiero D.J., Kitabayashi I., Herr W., and Cleary M.L. Leukemia protooncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24 (2004) 5639-5649
18. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., and Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123 (2005) 207-218
19. Hughes C.M., Rozenblatt-Rosen O., Milne T.A., Copeland T.D., Levine S.S., Lee J.C., Hayes D.N., Shanmugam K.S., Bhattacharjee A., Biondi C.A., Kay G.F., Hayward N.K., Hess J.L., and Meyerson M. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13 (2004) 587-597
20. Sowa H., Kaji H., Hendy G.N., Canaff L., Komori T., Sugimoto T., and Chihara K. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J. Biol. Chem. 279 (2004) 40267-40275
21. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., and Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 24 (2000) 391-395
22. Bertolino P., Tong W.M., Herrera P.L., Casse H., Zhang C.X., and Wang Z.Q. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res. 63 (2003) 4836-4841
23. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., and Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-65
24. Matsumoto K., Yoshitomi H., Rossant J., and Zaret K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294 (2001) 559-563
25. Lawrence H.J., Helgason C.D., Sauvageau G., Fong S., Izon D.J., Humphries R.K., and Largman C. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89 (1997) 1922-1930
26. Geissler E.N., Liao M., Brook J.D., Martin F.H., Zsebo K.M., Housman D.E., and Galli S.J. Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat. Cell Molec. Gen. 17 (1991) 207-214
27. Jensen R.T. Pancreatic endocrine tumors: recent advances. Ann. Oncol. 10 Suppl. 4 (1999) 170-176
28. Wilson M.E., Yang K.Y., Kalousova A., Lau J., Kosaka Y., Lynn F.C., Wang J., Mrejen C., Episkopou V., Clevers H.C., and German M.S. The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. Diabetes 54 (2005) 3402-3409
29. Heit J.J., Apelqvist A.A., Gu X., Winslow M.M., Neilson J.R., Crabtree G.R., and Kim S.K. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443 (2006) 345-349
30. Radford D.M., Ashley S.W., Wells Jr. S.A., and Gerhard D.S. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res. 50 (1990) 6529-6533